November 28, 2023 By Morgen Ahearn The gene-editing technology CRISPR shows early promise as a therapeutic strategy for the aggressive and difficult-to-treat brain cancer known as primary glioblastoma, according to findings of a new study from Gladstone Institutes. UCSF Anesthesia and Perioperative Care resident Alex Perez, MD, PhD, performed much of the computational work for this groundbreaking research. Read more on the Gladstone website.
Jul 15, 2024 Dedication to Health Equity and Well-being - Recent Updates Diversity, Equity, and Inclusion Well-being
Jun 13, 2024 Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review Announcement